Effect of White Light on Fatigue Levels in Patients With Gynecological Cancer
Cancer-related Fatigue, Light; Therapy, Complications
About this trial
This is an interventional supportive care trial for Cancer-related Fatigue focused on measuring Cancer-related fatigue, White light therapy, Chemotherapy, Clinical trial
Eligibility Criteria
Inclusion Criteria:
- had a normal state of consciousness,
- had no communication disorders, did not work in the night shift,
- had a general fatigue level score of ≥1 according to the Brief Fatigue Inventory
Exclusion Criteria:
- had natural/artificial lenses,
- used medication that causes photosensitivity (tetracycline, doxycycline, nalidixic acid, voriconazole, amiodarone, hydrochlorothiazide, naproxen, piroxicam, chlorpromazine)
- had a change in their treatment plan in the last 6 weeks were not included in the study
Sites / Locations
- Eskisehir Osmangazi University Faculty of Medicine
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
white light intervention group
Control group
Between the second and the eighth days of the application phase, the patients in the intervention group were administered a standard white light at 10,000 Lux intensity by an independent nurse (RA1) in their home environment using a Litebook Elite light source (The Litebook Company Ltd., Medicine Hat, AB). The distance between the light source and the patient's face was set at 50 cm, and the intensity of the light for each patient was checked using a Lux Meter. The intervention was applied between 07:00 and 10:00 in the morning for 30 minutes without interruption, and it was continued for seven successive days. The light application procedure was followed based on the previous studies on oncology patients. The second and third evaluations of the fatigue status of patients were completed on the 9th and 21st days.